Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891020-08-000094
Filing Date
2008-04-15
Accepted
2008-04-15 17:26:21
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v37359e10vk.htm 10-K 1522787
2 EXHIBIT 23 v37359exv23.htm EX-23 2272
3 EXHIBIT 31.1 v37359exv31w1.htm EX-31.1 8509
4 EXHIBIT 31.2 v37359exv31w2.htm EX-31.2 8820
5 EXHIBIT 32.1 v37359exv32w1.htm EX-32.1 3887
6 EXHIBIT 32.2 v37359exv32w2.htm EX-32.2 3681
7 GRAPHIC v37359v3735901.gif GRAPHIC 9675
8 GRAPHIC v37359v3735902.gif GRAPHIC 13450
9 GRAPHIC v37359v3735903.gif GRAPHIC 58081
10 GRAPHIC v37359v3735904.gif GRAPHIC 5273
11 GRAPHIC v37359v3735905.gif GRAPHIC 5430
12 GRAPHIC v37359v3735900.gif GRAPHIC 11198
  Complete submission text file 0000891020-08-000094.txt   1694358
Mailing Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVE. SUITE 750 BETHESDA MD 20814 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-33393 | Film No.: 08758206
SIC: 2834 Pharmaceutical Preparations